JORDYN KOEHLER: Open Payments
NPI 1285230177 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$242 in 12 payments from 7 companies in 2025. Trend: 2023 $158 · 2024 $347 · 2025 $242
Food & beverage: $242
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $77 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| ABBVIE INC. | 2 | $41 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: CAPLYTA, Auvelity, VRAYLAR, Jornay PM, FANAPT, COBENFY, REXULTI.
Industry payments across NC — which companies pay providers there.
